Home
Conditions
Hepatic Encephalopathy

Clinical trial condition

Hepatic Encephalopathy

Explore clinical trials studying Hepatic Encephalopathy. Study availability and eligibility vary by location and protocol.

139 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Hepatic Encephalopathy trial results

Completed

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

NCT01966419

Conditions: Acute Episode of Overt Hepatic Encephalopathy, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations: Phoenix, Arizona, United States

Phoenix, Arizona, United States

Little Rock, Arkansas, United States

Coronado, California, United States

View all 131 locations

View Trial Details

Completed

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

NCT03712280

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +14 more
Locations: Southern California Research Center Coronado, California, United States

Inland Empire Clinical Trials Rialto, California, United States

Global Clinical Professionals St. Petersburg, Florida, United States

American Research Corporation at the Texas Liver Institute San Antonio, Texas, United States

View Trial Details

Completed

Oral Fecal Transplant in Cirrhosis

NCT03152188

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +13 more
Locations: Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States

Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

NCT01041755

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +11 more
Locations: Hospital Universitario "José Eleuterio González" Monterrey, Nuevo León, Mexico

View Trial Details

Completed

The Effect of Induced Hyperammonaemia on Sleep and Melanopsin-mediated Pupillary Light Response in Patients With Liver Cirrhosis

NCT04771104

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +16 more
Locations: Department of gastroenterology and hepatology, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy

NCT04787276

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Microbial Resistance of Rifaximin in Hepatic Encephalopathy

NCT04736836

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF

NCT02786836

Conditions: Acute Liver Failure, Brain Diseases, Brain Diseases, Metabolic, +10 more
Locations: University of Alabama, Birmingham Birmingham, Alabama, United States

University of California, San Francisco San Francisco, California, United States

Yale University School of Medicine New Haven, Connecticut, United States

Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Rifaximin in Minimal Hepatic Encephalopathy

NCT00533910

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
Locations: Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States

View Trial Details

Completed

Minimal Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasian

NCT03586115

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Brain Diseases, +13 more
Locations: Policlinic Hospital Bari, Italy

View Trial Details

Hepatic Encephalopathy

Hepatic Encephalopathy trial results

Related conditions